7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine
|
|
|
- CAS-Nr.
- 1337531-36-8
- Englisch Name:
- 7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine
- Synonyma:
- GSK2606414;CS-868;NSC231323;NSC 231323;NSC-231323;Lactosit Miruhen;GSK2606414, >=98%;GSK2606414 (Free base);GSK2606414;GSK-2606414;PERK inhibitor GS2606414
- CBNumber:
- CB62616980
- Summenformel:
- C24H20F3N5O
- Molgewicht:
- 451.44
- MOL-Datei:
- 1337531-36-8.mol
|
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine Eigenschaften
- Schmelzpunkt:
- 176 - 180°C
- Siedepunkt:
- 720.3±60.0 °C(Predicted)
- Dichte
- 1.43±0.1 g/cm3(Predicted)
- storage temp.
- Hygroscopic, -20°C Freezer, Under inert atmosphere
- Löslichkeit
- DMSO (Slightly), Methanol (Slightly)
- pka
- 5.76±0.30(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Off-White to Pale Yellow
Sicherheit
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
GSK 2606414 acts as a potent and selective inhibitor of protein kinase R and similarly endoplasmic reticulum kinase affecting numerous diseases such as cancer.
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 128)Lieferanten
- 7-Methyl-5-[1-[[3-(trifluoromethyl)phenyl]acetyl]-2,3-dihydro-1H-indol-5-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine GSK2606414
- GSK2606414/ 7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine
- GSK2606414, >=98%
- GSK2606414 (Free base)
- GSK2606414;GSK 2606414;GSK-2606414
- 1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-indolin-1-yl)-2-(3-(trifluoromethyl)ph
- 7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine
- NSC 231323
- NSC231323
- NSC-231323
- 1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone
- GSK2606414;GSK-2606414
- 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]ethanone
- PERK inhibitor GS2606414
- CS-868
- Ethanone, 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]-
- 7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine USP/EP/BP
- GSK2606414,acell-permeableandorallyavailablePERKinhibitor
- Lactosit Miruhen
- GSK2606414
- 1337531-36-8
- C24H20F3N5O
- Inhibitors
